Oisin Biotechnologies, Inc. — Form D
Oisin Biotechnologies, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-12. The offering totals $17.9M, of which $5.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-07-12
- Form: D
- Accession: 0001801885-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $17.9M
- Amount sold: $5.4M
- Remaining: $12.5M
- Investors: 36
- Date of first sale: 2024-06-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-518582
Issuer
- Name: Oisin Biotechnologies, Inc.
- CIK: 0001801885
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 800 5TH AVENUE, SUITE 4100, SEATTLE, WA, 98104
- Phone: 206-880-1166
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| David Gobel | Director | Seattle, WA |
| Gary Hudson | Director | Seattle, WA |
| Danjuma Quarless | Director | Seattle, WA |
| Matthew Scholz | Director | Seattle, WA |
| Eric Garcia | Executive Officer | Seattle, WA |
| Stephen Hilbert | Executive Officer | Seattle, WA |
| Gary Hudson | Executive Officer | Seattle, WA |
| John Lewis | Executive Officer | Gibsonia, PA |
| Matthew Scholz | Executive Officer | Seattle, WA |
| Steve Hilbert | Executive Officer | Seattle, WA |
Other filings by this issuer (4)
More